India Digest: BYJU's accused of financial misconduct, Biological E looks to raise $250m

Edtech firm BYJU’s is being accused of financial misconduct by US-based fund manager Davidson Kempner Capital Management, reported The Morning Context on Monday. While Indian vaccine maker Biological E is in talks with General Atlantic, TA Associates and others to raise up to $250 million, according to VCCircle.